These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 23372643)

  • 1. PPAR-γ activation increases insulin secretion through the up-regulation of the free fatty acid receptor GPR40 in pancreatic β-cells.
    Kim HS; Hwang YC; Koo SH; Park KS; Lee MS; Kim KW; Lee MK
    PLoS One; 2013; 8(1):e50128. PubMed ID: 23372643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G Protein-coupled Receptor 40 (GPR40) and Peroxisome Proliferator-activated Receptor γ (PPARγ): AN INTEGRATED TWO-RECEPTOR SIGNALING PATHWAY.
    Wang S; Awad KS; Elinoff JM; Dougherty EJ; Ferreyra GA; Wang JY; Cai R; Sun J; Ptasinska A; Danner RL
    J Biol Chem; 2015 Aug; 290(32):19544-57. PubMed ID: 26105050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free fatty acids increase cytosolic free calcium and stimulate insulin secretion from beta-cells through activation of GPR40.
    Schnell S; Schaefer M; Schöfl C
    Mol Cell Endocrinol; 2007 Jan; 263(1-2):173-80. PubMed ID: 17101212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosiglitazone stimulates the release and synthesis of insulin by enhancing GLUT-2, glucokinase and BETA2/NeuroD expression.
    Kim HS; Noh JH; Hong SH; Hwang YC; Yang TY; Lee MS; Kim KW; Lee MK
    Biochem Biophys Res Commun; 2008 Mar; 367(3):623-9. PubMed ID: 18191635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulinotropic effects of GPR120 agonists are altered in obese diabetic and obese non-diabetic states.
    Zhang D; So WY; Wang Y; Wu SY; Cheng Q; Leung PS
    Clin Sci (Lond); 2017 Feb; 131(3):247-260. PubMed ID: 27980130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1.
    Mancini AD; Bertrand G; Vivot K; Carpentier É; Tremblay C; Ghislain J; Bouvier M; Poitout V
    J Biol Chem; 2015 Aug; 290(34):21131-21140. PubMed ID: 26157145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetuin A promotes lipotoxicity in β cells through the TLR4 signaling pathway and the role of pioglitazone in anti-lipotoxicity.
    Shen X; Yang L; Yan S; Zheng H; Liang L; Cai X; Liao M
    Mol Cell Endocrinol; 2015 Sep; 412():1-11. PubMed ID: 25986658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPAR-γ activation increases insulin secretion independent of CASK in INS-1 cells.
    Zhang K; Yuan Q; Xie J; Yuan L; Wang Y
    Acta Biochim Biophys Sin (Shanghai); 2019 Jul; 51(7):715-722. PubMed ID: 31168600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor-gamma regulates expression of PDX-1 and NKX6.1 in INS-1 cells.
    Moibi JA; Gupta D; Jetton TL; Peshavaria M; Desai R; Leahy JL
    Diabetes; 2007 Jan; 56(1):88-95. PubMed ID: 17192469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of peroxisome proliferator-activated receptor-gamma protects pancreatic beta-cells from cytokine-induced cytotoxicity via NF kappaB pathway.
    Kim EK; Kwon KB; Koo BS; Han MJ; Song MY; Song EK; Han MK; Park JW; Ryu DG; Park BH
    Int J Biochem Cell Biol; 2007; 39(6):1260-75. PubMed ID: 17521952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPARγ signaling and emerging opportunities for improved therapeutics.
    Wang S; Dougherty EJ; Danner RL
    Pharmacol Res; 2016 Sep; 111():76-85. PubMed ID: 27268145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiazolidinediones induce proliferation of human bronchial epithelial cells through the GPR40 receptor.
    Gras D; Chanez P; Urbach V; Vachier I; Godard P; Bonnans C
    Am J Physiol Lung Cell Mol Physiol; 2009 Jun; 296(6):L970-8. PubMed ID: 19346435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion.
    Edfalk S; Steneberg P; Edlund H
    Diabetes; 2008 Sep; 57(9):2280-7. PubMed ID: 18519800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of GPR40 attenuates chronic inflammation induced impact on pancreatic β-cells health and function.
    Verma MK; Sadasivuni MK; Yateesh AN; Neelima K; Mrudula S; Reddy M; Smitha R; Biswas S; Chandravanshi B; Pallavi PM; Oommen AM; Jagannath MR; Somesh BB
    BMC Cell Biol; 2014 Jun; 15():24. PubMed ID: 24974801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between GPR40 and lipotoxicity of the pancreatic β-cells as well as the effect of pioglitazone.
    Wu P; Yang L; Shen X
    Biochem Biophys Res Commun; 2010 Dec; 403(1):36-9. PubMed ID: 21036144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role and mechanism of rosiglitazone on the impairment of insulin secretion induced by free fatty acids on isolated rat islets.
    Tian JY; Li G; Gu YY; Zhang HL; Zhou WZ; Wang X; Zhu HD; Luo TH; Luo M
    Chin Med J (Engl); 2006 Apr; 119(7):574-80. PubMed ID: 16620699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPAR-γ activation restores pancreatic islet SERCA2 levels and prevents β-cell dysfunction under conditions of hyperglycemic and cytokine stress.
    Kono T; Ahn G; Moss DR; Gann L; Zarain-Herzberg A; Nishiki Y; Fueger PT; Ogihara T; Evans-Molina C
    Mol Endocrinol; 2012 Feb; 26(2):257-71. PubMed ID: 22240811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPR40 protein levels are crucial to the regulation of stimulated hormone secretion in pancreatic islets. Lessons from spontaneous obesity-prone and non-obese type 2 diabetes in rats.
    Meidute Abaraviciene S; Muhammed SJ; Amisten S; Lundquist I; Salehi A
    Mol Cell Endocrinol; 2013 Dec; 381(1-2):150-9. PubMed ID: 23911664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with CNX-011-67, a novel GPR40 agonist, delays onset and progression of diabetes and improves beta cell preservation and function in male ZDF rats.
    Gowda N; Dandu A; Singh J; Biswas S; Raghav V; Lakshmi MN; Shilpa PC; Sunil V; Reddy A; Sadasivuni M; Aparna K; Verma MK; Moolemath Y; Anup MO; Venkataranganna MV; Somesh BP; Jagannath MR
    BMC Pharmacol Toxicol; 2013 May; 14():28. PubMed ID: 23692921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human insulin gene transcription by peroxisome proliferator-activated receptor gamma and thiazolidinedione oral antidiabetic drugs.
    Schinner S; Krätzner R; Baun D; Dickel C; Blume R; Oetjen E
    Br J Pharmacol; 2009 Jul; 157(5):736-45. PubMed ID: 19338578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.